Global med-tech firms, India locked in tussle after stent price sting

NEW DELHI/MUMBAI (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for

Mystery deaths in Liberia linked to funeral: WHO

GENEVA (Reuters) - Nine people have died and eight are sick in Liberia after attending the funeral of a religious leader, the World Health Organization (WHO) said on Friday.

UK cancer fund was poor value and may have caused patient suffering

LONDON (Reuters) - A special U.K. Cancer Drugs Fund (CDF) set up in 2010 spent over 1.2 billion pounds ($1.55 bln) but failed to deliver value for patients or society and may have caused unnecessary suffering, an analysis has found.